ask="44.04"
ask_size="500"
average_daily_volume="1108450"
bid="40.00"
bid_size="100"
book_value="4.05"
change="-0.35"
change_from_200_day_moving_average="-5.75"
change_from_50_day_moving_average="-0.21"
change_from_52_week_high="-13.88"
change_From_52_week_low="10.02"
change_in_percent="-0.84%"
close="41.27"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.63"
eps_estimate_next_quarter="-0.48"
eps_estimate_next_year="-1.81"
ex_dividend_date="N/A"
float_shares="85807000"
high="41.89"
high_52_weeks="55.15"
last_trade_date="1/20/2017"
last_trade_price="41.27"
last_trade_size="133813"
last_trade_time="4:00pm"
low="40.80"
low_52_weeks="31.25"
market_capitalization="3.59B"
moving_average_200_day="47.02"
moving_average_50_day="41.48"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="66.92"
open="41.60"
pe_ratio="N/A"
peg_ratio="0.70"
percent_change_from_200_day_moving_average="-12.23%"
percent_change_from_50_day_moving_average="-0.51%"
percent_change_from_52_week_high="-25.17%"
percent_change_from_52_week_low="+32.06%"
previous_close="41.62"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="10.28"
price_per_sales="241.04"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.55"
stock_exchange="NMS"
symbol="NBIX"
volume="768940"
weeks_range_52="31.25 - 55.15"
